Is a complete LON/0JXI research report available?

No complete published report is available for lon/0JXI (LON/0JXI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

LON/0JXI (LON/0JXI)

London Stock Exchange: LON/0JXI · USD

$544

-0.62 (-0.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-28 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LON/0JXI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.4B
Revenue (ttm)	857.6M
Net income (ttm)	-234.3M
EPS (ttm)	-$10.3
Volume	5
Beta	-1.06

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 857.6M
Net income (ttm): -234.3M
EPS (ttm): -$10.3
Market cap: 9.4B

All LON/0JXI indicators

Market & fundamental data

Available fields

166

Groups with data

Currency

USD

Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	915
Employees Change	387%
Employees Change Percent	73.3
Enterprise value	$9.1B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Isin	US5588681057
Last refreshed	2026-07-28
Market cap	$9.4B
Price	$544
Price currency	USD
Rev Per Employee	937,311.85x
Sic	2834
Symbol	lon/0JXI
Website	https://www.madrigalpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.49%
EV/Sales	10.67x
FCF yield	-2.19%
P/B ratio	22.86x
P/S ratio	10.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-27.68%
EBITDA Margin	-27.55%
Gross margin	93.07%
Gross Profit	$798.2M
Gross Profit Growth	243.73%
Gross Profit Growth Q	114.33%
Net Income	$-234.3M
Pretax Margin	-27.32%
Profit Margin	-27.32%
Profit Per Employee	$-256,107
ROA	-17.62
Roa5y	-42.5
ROCE	-35.26
ROE	-49.35
Roe5y	-101.6
ROIC	-22.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	80.86%
Cagr3y	36.56%
Cagr5y	40.23%
Revenue Growth	256.82x
Revenue Growth Q	126.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.02
Assets	$929.5M
Cash	$615.5M
Current Assets	$888.2M
Current Liabilities	$254.1M
Debt	$263M
Debt Equity	$0.64
Debt FCF	$-1.27
Equity	$411.6M
Interest Coverage	-11.68
Liabilities	$517.9M
Long Term Assets	$41.2M
Long Term Liabilities	$263.8M
Net Cash	$352.5M
Net Cash By Market Cap	$3.75
Net Cash Growth	-35.65%
Net Debt Equity	$-0.86
Tangible Book Value	$406M
Tangible Book Value Per Share	$17.62
WACC	-1.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.5
Inventory Turnover	0.94
Net Working Capital	$25M
Quick ratio	2.96
Working Capital	$639.2M
Working Capital Turnover	$1.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	80.79%
200-day SMA	504.6
3Y total return	154.75%
50-day SMA	517.3
50-day SMA vs 200-day SMA	50over200
5Y total return	442.1%
All Time High	610.6
All Time High Change	-10.89%
All Time High Date	2025-12-24
All Time Low	57.67
All Time Low Change	843.49%
All Time Low Date	2022-01-31
ATR	18.52
Beta	-1.06
Ch YTD	-7.56
High	551
High52	610.6
High52 Date	2025-12-24
High52ch	-10.89%
Low	535
Low52	291
Low52 Date	2025-07-30
Low52ch	86.98%
Ma50ch	5.18%
Price vs 200-day SMA	7.83%
RSI	61.41
RSI Monthly	63.09
RSI Weekly	62.45
Sharpe ratio	1.45x
Sortino ratio	2.59
Total Return	2.67%
Tr YTD	-7.56
Tr1m	3.44%
Tr1w	1.36%
Tr3m	3.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-237.4M
Operating margin	-27.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,849,969%
Net Borrowing	171,544,955.1
Shares Insiders	5.25%
Shares Institutions	73.75%
Shares Qo Q	27.17%
Shares Yo Y	-2.67%
Short Ratio	6.29

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-290.5M
Adjusted OCF	-287,256,389
Average Volume	44.1x
Bv Per Share	17.86
CAPEX	$-3.3M
Ch1m	3.44
Ch1w	1.36
Ch1y	80.79
Ch3m	3.61
Ch3y	154.7
Ch5y	442.1
Ch6m	9.79
Change	-0.11%
Change From Open	-1.25
Close	544.7
Days Gap	1.15
Depreciation Amortization	1,136,691.2
Dollar Volume	2,720.6
Earnings Date	2026-07-30
EBIT	$-237.4M
EBITDA	$-236.3M
EPS	$-10.34
F Score	2
FCF	$-206.3M
FCF EV Yield	-2.28x
Financing CF	189,078,611
Fiscal Year End	December
Founded	2,016
Investing CF	45,917,674
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	506.3
Ma150ch	7.47%
Ma20	538.3
Ma20ch	1.07%
Net CF	32,974,574
Next Earnings Date	2026-07-30
Open	551
Position In Range	56.94
Ppne	10,696,767.4
Price Date	2026-07-24
Ptbv Ratio	23.17
Relative Volume	0.15x
Revenue	857,640,339x
SBC By Revenue	9.82x
Share Based Comp	84,225,190
Tr6m	9.79%
Volume	5
Z Score	6.61

LON/0JXI (LON/0JXI)

Coverage state: Market snapshot only — no published research

Generate the first LON/0JXI analysis

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0JXI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0JXI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LON/0JXI

Frequently asked questions